Cargando…
Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline
BACKGROUND: While histopathologic changes correlate with functional impairment in cross-sectional studies of diabetic nephropathy (DN), whether these findings predict future rate of kidney function loss remains uncertain. We thus sought to examine the relationship between kidney histopathology, inci...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368674/ https://www.ncbi.nlm.nih.gov/pubmed/32682403 http://dx.doi.org/10.1186/s12882-020-01943-1 |
_version_ | 1783560641997438976 |
---|---|
author | Misra, Paraish S. Szeto, Stephen G. Krizova, Adriana Gilbert, Richard E. Yuen, Darren A. |
author_facet | Misra, Paraish S. Szeto, Stephen G. Krizova, Adriana Gilbert, Richard E. Yuen, Darren A. |
author_sort | Misra, Paraish S. |
collection | PubMed |
description | BACKGROUND: While histopathologic changes correlate with functional impairment in cross-sectional studies of diabetic nephropathy (DN), whether these findings predict future rate of kidney function loss remains uncertain. We thus sought to examine the relationship between kidney histopathology, incidence of end-stage kidney disease (ESKD), and rate of estimated glomerular filtration rate (eGFR) loss in DN. METHODS: In this longitudinal cohort study, we studied 50 adults diagnosed with biopsy-proven DN. We analyzed the histopathologic parameters of each patient’s kidney biopsy, as defined by the Renal Pathology Society classification system for DN, and tracked all available eGFR measurements post-biopsy. We additionally collected baseline clinical parameters (at the time of biopsy), including eGFR, albumin-to-creatinine ratio (ACR), and hemoglobin A(1c). Multivariable linear regression was used to assess the relationship between histologic and clinical parameters at the time of the biopsy and eGFR slope. Kaplan-Meier curves and Cox regression were used to evaluate the association between histologic and clinical parameters and ESKD incidence. RESULTS: Progression to ESKD was associated with worsening interstitial fibrosis score (p = 0.05), lower baseline eGFR (p = 0.02), higher ACR (p = 0.001), and faster eGFR decline (p < 0.001). The rate of eGFR decline did not associate with any histologic parameter. Baseline ACR was the only studied variable correlating with eGFR slope (rho = − 0.41). CONCLUSIONS: Renal histology predicts ultimate progression to ESKD, but not the rate of progression. Future work is required to identify novel predictors of rapid functional decline in patients with diabetic nephropathy. |
format | Online Article Text |
id | pubmed-7368674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73686742020-07-20 Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline Misra, Paraish S. Szeto, Stephen G. Krizova, Adriana Gilbert, Richard E. Yuen, Darren A. BMC Nephrol Research Article BACKGROUND: While histopathologic changes correlate with functional impairment in cross-sectional studies of diabetic nephropathy (DN), whether these findings predict future rate of kidney function loss remains uncertain. We thus sought to examine the relationship between kidney histopathology, incidence of end-stage kidney disease (ESKD), and rate of estimated glomerular filtration rate (eGFR) loss in DN. METHODS: In this longitudinal cohort study, we studied 50 adults diagnosed with biopsy-proven DN. We analyzed the histopathologic parameters of each patient’s kidney biopsy, as defined by the Renal Pathology Society classification system for DN, and tracked all available eGFR measurements post-biopsy. We additionally collected baseline clinical parameters (at the time of biopsy), including eGFR, albumin-to-creatinine ratio (ACR), and hemoglobin A(1c). Multivariable linear regression was used to assess the relationship between histologic and clinical parameters at the time of the biopsy and eGFR slope. Kaplan-Meier curves and Cox regression were used to evaluate the association between histologic and clinical parameters and ESKD incidence. RESULTS: Progression to ESKD was associated with worsening interstitial fibrosis score (p = 0.05), lower baseline eGFR (p = 0.02), higher ACR (p = 0.001), and faster eGFR decline (p < 0.001). The rate of eGFR decline did not associate with any histologic parameter. Baseline ACR was the only studied variable correlating with eGFR slope (rho = − 0.41). CONCLUSIONS: Renal histology predicts ultimate progression to ESKD, but not the rate of progression. Future work is required to identify novel predictors of rapid functional decline in patients with diabetic nephropathy. BioMed Central 2020-07-18 /pmc/articles/PMC7368674/ /pubmed/32682403 http://dx.doi.org/10.1186/s12882-020-01943-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Misra, Paraish S. Szeto, Stephen G. Krizova, Adriana Gilbert, Richard E. Yuen, Darren A. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline |
title | Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline |
title_full | Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline |
title_fullStr | Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline |
title_full_unstemmed | Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline |
title_short | Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline |
title_sort | renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368674/ https://www.ncbi.nlm.nih.gov/pubmed/32682403 http://dx.doi.org/10.1186/s12882-020-01943-1 |
work_keys_str_mv | AT misraparaishs renalhistologyindiabeticnephropathypredictsprogressiontoendstagekidneydiseasebutnottherateofrenalfunctiondecline AT szetostepheng renalhistologyindiabeticnephropathypredictsprogressiontoendstagekidneydiseasebutnottherateofrenalfunctiondecline AT krizovaadriana renalhistologyindiabeticnephropathypredictsprogressiontoendstagekidneydiseasebutnottherateofrenalfunctiondecline AT gilbertricharde renalhistologyindiabeticnephropathypredictsprogressiontoendstagekidneydiseasebutnottherateofrenalfunctiondecline AT yuendarrena renalhistologyindiabeticnephropathypredictsprogressiontoendstagekidneydiseasebutnottherateofrenalfunctiondecline |